Epstein–Barr Virus-Induced B-Cell Lymphoma after Renal Transplantation: Acyclovir Therapy and Transition from Polyclonal to Monoclonal B-Cell Proliferation

New England Journal of Medicine

Volumn 306, Issue 15, 1982, Pages 913-918

  Hanto, Douglas W ^a   Frizzera, Glauco ^a   Gajl Peczalska, Kazimiera J ^a   Sakamoto, Kiyoshi ^a   Purtilo, David T ^a   Balfour, Henry H ^a   Simmons, Richard L ^a   Najarian, John S ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; AZATHIOPRINE; PREDNISONE;

B CELL LYMPHOMA; B LYMPHOCYTE; CASE REPORT; EPSTEIN BARR VIRUS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPHATIC SYSTEM; LYMPHOCYTE TRANSFORMATION; LYMPHOMA; SCHOOL CHILD; THERAPY;

EID: 0020471814     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198204153061506     Document Type: Article

References (20)

1. Henle G., Henle W. The virus as the etiologic agent of infectious mononucleosis. In: Epstein MA, Achong BG, eds. The Epstein–Barr virus. Berlin: Springer-Verlag, 1979: 297-320.
2. Klein G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proc Natl Acad Sci USA. 1979; 76:2442-2446
3. Klein G. The relationship of the virus to nasopharyngeal carcinoma. In: Epstein MA, Achong BG, eds. The Epstein–Barr virus. Berlin: Springer-Verlag, 1979: 339-50.
4. Purtilo D.T., Sakamoto K., Saemundsen A.K., et al. Documentation of Epstein–Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies. Cancer Res. 1981; 41:4226-4236
5. Hanto D.W., Frizzera G., Purtilo D.T., et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of the Epstein–Barr virus. Cancer Res. 1981; 41:4253-4261
6. Frizzera G., Hanto D.W., Gajl-Peczalska K.J., et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res. 1981; 41:4262-4279
7. Elion G.B., Furman P.A., Fyfe J.A., de Miranda P., Beauchamp L., Schaeffer H.J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc Natl Acad Sci USA. 1977; 74:5716-5720
8. Colby B.M., Shaw J.E., Elion G.B., Pagano J.S. Effect of acyclovir [9-(2hydroxyethoxymethyl)guanine] on Epstein–Barr virus DNA replication. J Virol. 1980; 34:560-568
9. Datta A.K., Colby B.M., Shaw J.E., Pagano J.S. Acyclovir inhibition of Epstein–Barr virus replication. Proc Natl Acad Sci USA. 1980; 77:5163-5166
10. Mitchell C.D., Bean B., Gentry S.R., Groth K.E., Boen J.R., Balfour H.H. Jr. Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet. 1981; 1:1389-1392
11. Lukes R.J., Collins R.D. Immunologic characterization of human malignant lymphomas. Cancer. 1974; 34: Suppl:1488-1503
12. Bloomfield C.D., Gajl-Peczalska K.J. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma. In: Piomelli S, Yachnin S, eds. Curr Top Hematol. Vol. 3. 1980: 175-240.
13. Abramson C.S., Kersey J.H., LeBien T.W. A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. J Immunol. 1981; 126:83-88
14. Reedman B.M., Klein G. Cellular localization of an Epstein–Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973; 11:499-520.
15. Saemundsen A.K., Purtilo D.T., Sakamoto K., et al. Documentation of Epstein–Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative disease by Epstein–Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res. 1981; 41:4237-4242
16. Hanto D.W., Sakamoto K., Purtilo D.T., Simmons R.L., Najarian J.S. The Epstein–Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders: clinical, pathologic, and virologic correlation. Surgery. 1981; 90:204-213
17. Chang R.S., Lewis J.P., Reynolds R.D., Sullivan M.J., Neuman J. Oropharyngeal excretion of Epstein–Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts. Ann Intern Med. 1978; 88:34-40.
18. Ernberg I., Klein G. EB virus-induced antigens. In: Epstein MA, Achong BG, eds. The Epstein–Barr virus. Berlin: Springer-Verlag, 1979: 39-60.
19. Rosen A., Gergely P., Jondal M., Klein G., Britton S. Polyclonal Ig production after Epstein–Barr virus infection of human lymphocytes in vitro. Nature. 1977; 267:52-54
20. Zulman J., Jaffe R., Talal N. Evidence that the malignant lymphoma of Sjögrens syndrome is a monoclonal B-cell neoplasm. N Engl J Med. 1978; 299:1215-1220